WeVote

Bill

Bill

AB 1027

Cannabis: testing: quality assurance.

2025-2026 Regular Session Introduced by Heather Hadwick and 1 co-sponsor

AB 1027 strengthens cannabis product testing and quality assurance standards in California to improve consumer safety and market oversight, pending budget committee approval.

In committee: Held under submission.
0
WeVote Research Nonpartisan
Bill Summary · AB 1027

Legislative bill overview

AB 1027 establishes enhanced testing and quality assurance requirements for cannabis products sold in California. The bill appears to strengthen regulatory oversight of the cannabis supply chain through improved laboratory testing standards and quality control measures.

Why is this important

California's legal cannabis market requires robust testing to ensure consumer safety and product integrity, particularly regarding potency, contaminants, and pesticides. Strengthened quality assurance standards can reduce public health risks, increase consumer confidence, and create competitive fairness among licensed producers who comply with regulations versus illicit operators.

Potential points of contention

  • Compliance costs: Enhanced testing requirements may increase operational expenses for cultivators and retailers, potentially raising prices or squeezing margins for smaller businesses
  • Laboratory capacity and access: Stricter standards require sufficient certified testing labs; rural areas or underserved regions may face delays or limited testing availability
  • Regulatory clarity: Amendments throughout the process suggest ongoing debate about specific testing thresholds, methodologies, or which products/categories are covered

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.